BeamMed Inc. at the 15th Medicare Stars HEDIS Quality & Risk Forum, Showcasing Portable Bone Density Screening Solutions That Drive HEDIS Measure Compliance

BeamMed Inc. will exhibit at the 15th Medicare Stars HEDIS Quality & Risk Forum (June 2-4, 2026, Chicago, IL), showcasing its portable MiniOmni Trademark bone density scanner and AI fundus camera to help Medicare Advantage plans improve HEDIS OMW & OSW compliance and Star Ratings.
As Medicare Advantage plans face mounting pressure to improve Star Ratings and HEDIS performance scores in a climate of tightening CMS budgets and evolving quality benchmarks, one question is defining strategy in boardrooms and care management teams alike: How do health plans close persistent gaps in osteoporosis screening and bone health monitoring for their Medicare populations?

BeamMed Inc., a global leader in portable bone density screening devices, will be exhibiting at the 15th Medicare Stars, HEDIS Registered Quality & Risk Forum 2026, taking place June 2-4, 2026 at the Hilton Rosemont O'Hare, Chicago, Illinois. The company will demonstrate how its innovative, point-of-care screening solutions are helping Medicare Advantage plans and their provider networks measurably improve HEDIS OMW and OSW compliance - and by extension, elevate their overall Star Ratings.

Why the Medicare Stars HEDIS Quality & Risk Forum Matters in 2026

The 15th annual Medicare Stars HEDIS Quality & Risk Forum is one of the healthcare industry's most critical convenings for Medicare Advantage plan leaders, quality directors, HEDIS analytics teams, risk adjustment professionals, and care management executives. With more than 15 Medicare Advantage plan experts slated to present, the 2026 summit delivers actionable strategies to navigate the latest CMS and NCQA regulatory updates, optimize member engagement, and leverage data and AI tools for smarter quality improvement.

Key themes at this year's forum include:

* Boosting Star Ratings through cross-functional member and provider engagement
* Improving HEDIS Registered measure performance under tighter operational budgets
* Ensuring compliance with evolving CMS and NCQA standards
* Leveraging AI and data analytics for smarter care delivery decisions
* Streamlining data collection, gap closure, and provider collaboration

For BeamMed, this forum is not just a networking opportunity - it's a platform to connect the dots between clinical-grade screening technology and the HEDIS quality measures that directly influence a plan's financial performance and member health outcomes.

The HEDIS Osteoporosis Gap: A Critical and Under Addressed Challenge

Osteoporosis remains one of the most undertreated and underdiagnosed conditions among Medicare-age women. According to the National Osteoporosis Foundation, approximately 10 million Americans have osteoporosis, yet screenings and follow-up care remain persistently low - a gap that directly impacts two core HEDIS measures:

* HEDIS OMW (Osteoporosis Management in Women who had a Fracture): Measures whether women aged 67-85 who suffered a fracture received a bone mineral density test or prescription treatment within six months.
* HEDIS OSW (Osteoporosis Screening in Older Women): Evaluates whether women aged 65-85 without prior fractures or diagnoses received a bone density test within two years.

Both measures directly affect a plan's Star Rating, making HEDIS OSW compliance [https://www.beammed.com/hedis-osw-helps-osteoporosis-patients-and-early-detection/] and OMW performance core priorities for any Medicare Advantage plan aiming to maintain or improve its competitive position. Closing these gaps requires accessible, accurate, and affordable bone density testing - exactly where BeamMed's technology delivers.

BeamMed's Solution: Portable Bone Density Screening at the Point of Care

BeamMed's flagship device, the Sunlight MiniOmni Trademark portable bone density scanner [https://www.beammed.com/miniomni-portable-bone-density-scanner-benefits-use-cases-and-roi-for-clinics/], is revolutionizing how primary care physicians, OB/GYN practices, and health system networks approach osteoporosis screening. Using proven quantitative ultrasound (QUS) technology - with no radiation, no dedicated room requirements, and no referral delays - the MiniOmni Trademark enables in-office bone density testing in just minutes.

Practical advantages for Medicare Advantage plans and their provider networks include:

* Rapid gap closure: Providers can screen eligible women during routine visits, dramatically increasing HEDIS OMW and OSW compliance rates.
* No radiation exposure: Safe for repeated use, making follow-up and monitoring straightforward.
* Portable and affordable: No costly infrastructure investment or scheduling delays typically associated with DXA imaging.
* Multi-site measurement capability: Assesses bone density at multiple anatomical sites for greater clinical accuracy.
* Seamless EHR integration: Results flow directly into clinical documentation, supporting care coordination and quality reporting.

Plans working with BeamMed have reported meaningful improvements in their HEDIS osteoporosis measure rates, translating into higher Star Ratings and stronger quality bonus payments.

What to Expect at BeamMed's Exhibit Booth in Chicago

Attendees of the 15th Medicare Stars HEDIS Quality & Risk Forum will have the opportunity to engage directly with BeamMed's clinical and commercial team during the summit. At the exhibit booth, visitors can expect:

* Live demonstrations of the MiniOmni Trademark bone density scanner
* Strategy consultations on improving HEDIS OMW and OSW measure performance
* A showcase of BeamMed's AI fundus camera, expanding screening capabilities for diabetic retinopathy screening - another key area of Medicare quality improvement
* Discussion of real-world ROI data from health plans and provider groups that have integrated BeamMed's technology
* Resources and frameworks for implementing point-of-care screening at scale across provider networks

Register now and plan your visit to BeamMed's booth at the 15th Medicare Stars HEDIS Quality & Risk Forum [https://www.beammed.com/events/15th-medicare-stars-hedis-quality-risk-summit-2026/] to discover how portable screening is reshaping quality improvement strategy for Medicare Advantage plans nationwide.

About BeamMed Inc.

BeamMed's product line offers innovative, non-invasive diagnostic solutions focused on bone and ocular health. Widely used across clinics, hospitals, and mobile healthcare programs throughout the U.S., these tools are designed to make early detection more accessible, efficient, and accurate. With a strong emphasis on usability and clinical performance, BeamMed's offerings continue to support the advancement of preventive care nationwide.

To learn more about these next-generation diagnostic tools, visit the following pages:

* Learn more about the Mini Omni Trademark Portable Bone Density Scanner [https://www.beammed.com/sunlight-miniomni/]
* Discover the AI-Powered Fundus Camera for intelligent eye screening [https://www.beammed.com/fundus-camera/]

These innovations represent the future of preventive care-accessible, accurate, and ready to make a difference in healthcare settings across the country.

Media Contact
Company Name: BeamMed Inc.
Contact Person: Gilad Zamir
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=beammed-inc-at-the-15th-medicare-stars-hedis-quality-risk-forum-showcasing-portable-bone-density-screening-solutions-that-drive-hedis-measure-compliance]
Phone: 800-769-6808
Address:950 S. Pine Island Road
City: Plantation
State: Florida
Country: United States
Website: http://www.beammed.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.